Detrick lab to study Ebola treatment

(Associated Press)
(Associated Press)
Set Text Size SmallSet Text Size MediumSet Text Size LargeSet Text Size X-Large
Share
Updated: 8/14 6:10 am

FREDERICK, Md. (AP) — Researchers at the Army Medical Research Institute of Infectious Diseases (USAMRIID) at Fort Detrick are planning a study on an experimental drug that was given to two American aid workers to treat the Ebola virus.

USAMRIID spokeswoman Caree Vander Linden said a study this fall will be designed to determine the ideal dose of a drug called ZMapp, produced by San Diego-based Mapp Biopharmaceutical Inc.

The Frederick News-Post reports that the study will involve primate subjects, not humans.

ZMapp is a mix of three specially engineered antibodies grown inside tobacco plants. The two American aid workers who received the drug appear to be improving, but it is not known whether their improvement is a result of receiving the drug.

USAMRIID has been studying Ebola for decades.


©2014 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Share
0 Comment(s)
Comments: Show | Hide

Here are the most recent story comments.View All

No comments yet!
NEWSCASTS ON DEMAND
WATCH OUR LIVE NEWSCAST

What's On

All content © Copyright 2014 Intermountain West Communications Company. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms of Service.
You may also view our Sitemap

Inergize Digital This site is hosted and managed by Inergize Digital.
Mobile advertising for this site is available on Local Ad Buy.